Skip to main content
. 2020 May 29;6(7):1951–1964. doi: 10.1021/acsinfecdis.0c00252

Table 3. Pharmacokinetic Parameters for 1 and 2 after Intravenous and Oral Administration.

  1
2
1 as metabolite of 2
parameter iv oral iv oral oral
dose (mg/kg) 5 20 5 20 20 of compound 2
Cmax (μM)   5.98   3.54 10.4
Tmax (h)   3   0.5 3
Vd (L/kg) 0.81   11.1    
apparent t1/2 (h) 7.3   6.2   10.4
CLtotal (mL·min–1·kg–1) 1.3   21.8    
AUC0–∞ (min·μmol·L–1) 8589 7249 523 2152 18430
bioavailability (%)   18.4   93